Decapping is a key step in mRNA turnover. However, the composition and regulation of the human decapping complex is poorly understood. Here, we identify three proteins that exist in complex with the decapping enzyme subunits hDcp2 and hDcp1: hEdc3, Rck/p54, and a protein in decapping we name Hedls. Hedls is important in decapping because it enhances the activity of the catalytic hDcp2 subunit and promotes complex formation between hDcp2 and hDcp1. Specific decapping factors interact with the mRNA decay activators hUpf1 and TTP, and TTP enhances decapping of a target AU-rich element (ARE) RNA in vitro. Each decapping protein localizes in cytoplasmic processing bodies (PBs), and overexpression of Hedls produces aberrant PBs and concomitant accumulation of a deadenylated ARE-mediated mRNA decay intermediate. These observations suggest that multiple proteins involved in human decapping are important subunits of PBs and are activated on ARE-mRNAs by the protein TTP.
Introduction mRNA turnover is a central process in regulation of gene expression. In Saccharomyces cerevisiae, degradation of most mRNAs is exonucleolytic and is generally initiated by deadenylation (Decker and Parker, 1993; Wilson and Treisman, 1988) , which is followed by decapping and 5 0 to 3 0 exonucleolytic degradation Couttet et al., 1997) . Alternatively, after deadenylation, the mRNA can be degraded from the 3 0 end by a complex of exonucleases termed the exosome (Mitchell et al., 1997; Anderson and Parker, 1998; Parker and Song, 2004) . Homologs of S. cerevisiae mRNA decay enzymes are found in the genomes of other eukaryotes, including humans, but their importance in mRNA decay is not well established (Bashkirov et al., 1997; Mitchell et al., 1997; Chen et al., 2001 Chen et al., , 2002 Lykke-Andersen, 2002; van Dijk et al., 2002; Wang et al., 2002) .
A key step in mRNA turnover is decapping, which precedes 5 0 to 3 0 exonucleolytic decay of the mRNA body. Several proteins involved in decapping have been identified in S. cerevisiae, including Dcp1, Dcp2, Lsm1-7, Dhh1, Edc1, Edc2, and Edc3 (reviewed in Coller and Parker [2004] , Cougot et al. [2004b] , and Fillman and Lykke-Andersen [2005] ). Dcp2 contains a NUDIX/mutT motif essential for decapping and catalyzes the removal of m7 GDP from capped RNAs in vitro (Dunckley and Parker, 1999; Steiger et al., 2003) . Dcp1 interacts with Dcp2 and greatly stimulates decapping (Dunckley and Parker, 1999; Beelman et al., 1996; Steiger et al., 2003) . Human homologs of Dcp1 (hDcp1a and hDcp1b) and Dcp2 (hDcp2) have been identified and shown to play a role in decapping (Piccirillo et al., 2003; van Dijk et al., 2002; Lykke-Andersen, 2002; Wang et al., 2002) .
In addition to Dcp proteins, the Lsm1-7 complex and the RNA helicase Dhh1 both promote decapping of mRNAs in S. cereviciae, and their deletion results in accumulation of deadenylated mRNA (Tharun and Parker, 2001; Sheth and Parker, 2003; Bouveret et al., 2000; Coller et al., 2001; Fischer and Weis, 2002; Salgado-Garrido et al., 1999; Achsel et al., 1999) . Human homologs of Lsm1-7 (hLsm1-7) and Dhh1 (Rck/p54) have been identified (Cougot et al., 2004a; Eystathioy et al., 2003; Ingelfinger et al., 2002) . The S. cerevisiae Edc1-Edc3 proteins are nonessential for decapping but enhance the activity of the decapping enzyme Kshirsagar and Parker, 2004; Dunckley et al., 2001) . Potential orthologs of Edc3 have been identified in other organisms, including humans, but these are all proteins of unknown function (Kshirsagar and Parker, 2004; Albrecht and Lengauer, 2004; Anantharaman and Aravind, 2004) .
In addition to the importance in general mRNA turnover, decapping also plays a central role in specialized mRNA decay pathways. For example, the nonsensemediated decay (NMD) pathway, which targets mRNAs with premature termination codons (PTCs) for rapid degradation, activates decapping in yeast and human cells Lejeune et al., 2003; Couttet and Grange, 2004) . NMD depends on three Upf proteins, Upf1, Upf2, and Upf3, but it is poorly understood how the Upf proteins activate decapping Jacobson, 1995, 2001; Lykke-Andersen, 2002) . However, both yeast and human Upf1 interact with Dcp2 (Lykke-Andersen, 2002; He and Jacobson, 1995) . Another mRNA decay pathway that activates decapping is responsible for the rapid turnover of mRNAs that contain AREs in their 3 0 untranslated regions (UTRs). In human cells, AREs appear to independently activate several distinct mRNA decay processes, including decapping (Chen et al., 1995 (Chen et al., , 2001 Lykke-Andersen and Wagner, 2005; Lai et al., 2003; Gao et al., 2001; Mukherjee et al., 2002; Wang and Kiledjian, 2001 Dijk et al., 2002; Sheth and Parker, 2003; Eystathioy et al., 2003; Ingelfinger et al., 2002; Kedersha et al., 2005) . Several lines of evidence indicate that these structures, referred to as PBs (also known as Dcpbodies or GW-bodies) are sites of mRNA decay (Cougot et al., 2004a; Sheth and Parker, 2003) . In addition, recent localization studies have implicated PBs in RNA interference and microRNA-induced translational silencing (Liu et al., 2005; Sen and Blau, 2005; Ding et al., 2005; Pillai et al., 2005) . However, the specific role of PBs in cellular mRNA decay and translation inhibition is poorly understood. It is therefore of great importance to understand the composition and function of PBs.
To uncover components of the decapping machinery and PBs, we affinity purified complexes containing the decapping subunits hDcp1a and hDcp1b and used mass spectrometry to identify interaction partners. We uncovered three proteins in human decapping: Rck/ p54 and hEdc3 (homologs of yeast Dhh1 and Edc3, respectively) and a component in decapping we call Hedls (human enhancer of decapping large subunit). We show that Hedls promotes the interaction between hDcp1 and hDcp2 and enhances decapping of hDcp2 in vitro. Moreover, overexpression of Hedls leads to formation of multiple aberrantly enlarged PBs and a concomitant accumulation of Hedls-associated deadenylated ARE-containing mRNA. Interestingly, NMD and AREmediated mRNA decay factors appear to interact with the decapping machinery through distinct subunits, and the protein TTP activates decapping of an AREcontaining RNA in vitro.
Results

Isolation of Three hDcp-Associated Proteins
To isolate proteins involved in decapping in human cells, we established human embryonic kidney (HEK) 293 cell lines that stably express FLAG-tagged hDcp1a and hDcp1b under the control of tetracycline inducible promoters. At low tetracycline concentrations, FLAGhDcp1a and FLAG-hDcp1b primarily colocalize with endogenous hDcp1a in cytoplasmic PBs ( Figure S1 available in the Supplemental Data online, and data not shown) and coprecipitate with endogenous hDcp1a, hDcp1b, and hDcp2 proteins ( Figure S2 ). These cell lines were therefore useful for purification of hDcp complexes.
We next analyzed FLAG-hDcp1 complexes by mass spectrometry. Anti-FLAG immunoprecipitates were prepared from cell lysates supplemented with 1 mg/ml FLAG peptide, which significantly reduces unspecific binding to the column ( Figure S3 ). Proteins that consistently copurified specifically with FLAG-hDcp proteins were subjected to analysis by mass spectrometry, which identified three hDcp-associated proteins: Rck/p54, hEdc3, and Hedls ( Figures 1A and 1B) . hDcp2 was not observed in the purified hDcp1 complexes, perhaps due to masking by the closely migrating Rck/p54 protein (see e.g., Figure 6B ). Rck/p54 and hEdc3 are homologs of yeast Dhh1 and Edc3, respectively, which are known stimulators of decapping (Coller et al., 2001; Kshirsagar and Parker, 2004; Badis et al., 2004; Fischer and Weis, 2002) . By contrast, Hedls has no obvious homolog in yeast and has not been previously implicated in decapping. A chaperone protein, HSPA1L, which copurified with FLAG-hDcp1a and FLAG-hDcp1b, is presumed to be a nonspecific interactor ( Figure 1A) .
To verify that the purified hDcp1-associated proteins exist in complex with endogenous hDcp1a, we prepared rabbit polyclonal antibodies against Hedls and hEdc3 (we were unsuccessful in preparing an antibody against Rck/p54). As shown in the coimmunoprecipitation assay in Figure 1C , endogenous Hedls and hEdc3 both exist in complex with hDcp1a (lane 3, top two panels). The RNA binding protein HuR, which served as a negative control, does not copurify with hDcp1a (lane 3, bottom) , and none of the tested proteins purify with a preimmune serum (lane 2). We have no data indicating that hDcp1b functions differently from hDcp1a in decapping, and in the following experiments, we focus entirely on hDcp1a. (A) Silver-stained SDS-polyacrylamide gels showing proteins that copurify with stably expressed FLAG-tagged hDcp1a (lane 1), or hDcp1b (lane 3), or proteins purified in a similar manner from ''parental'' cells expressing no FLAG-tagged protein (lanes 2 and 4). The asterisks (*) show proteins that are either nonspecific or did not reproducibly appear in repeated experiments. (B) Schematics of Rck/p54, hEdc3, and Hedls proteins (nucleotide sequence accession numbers NP004388, BAB15001, and AAH43616, respectively). Black bars, conserved domains (names given above); gray bars, regions of similarity to orthologs in other organisms. Numbers refer to amino acids (aa). (C) Western blots of anti-hDcp1a (lane 3) and preimmune (lane 2) immunoprecipitates from RNase-treated HeLa cell extracts. Immunoprecipitates were probed for endogenous Hedls, hEdc3, hDcp1a, and HuR and compared to 10% of the input extract (lane 1). IgG: Immunoglobulin G heavy chain.
Association between Overexpressed hDcp1a and hDcp2 Requires Coexpressed Hedls During the course of our experiments, we observed that hDcp1a and hDcp2 do not form a detectable complex when overexpressed in HEK293T cells (Figure 2A , lane 1). We also could not detect an interaction between bacterially produced glutathione S-transferase (GST)-tagged hDcp1a and hDcp2 translated in a rabbit reticulocyte lysate ( Figure S4 ). This was surprising because hDcp1a and hDcp2 coimmunopurify when expressed at low levels (compare Figure 2A , lane 1, and Figure S2 ; see also Lykke-Andersen [2002] ) and Dcp1 and Dcp2 are generally thought to form a heterodimeric decapping complex in yeast and human cells (Dunckley and Parker, 1999; van Dijk et al., 2002; Cougot et al., 2004a; LykkeAndersen, 2002) . We reasoned that overexpression of hDcp1a and hDcp2 in HEK 293T cells may render an endogenous protein limiting for complex formation. We therefore tested whether overexpressed hDcp1a and hDcp2 depend on a third subunit for interaction. Interestingly, Hedls fits this criterion, because whereas hDcp2 and Hedls do not individually associate with hDcp1a ( Figure 2 , lanes 1, 3, and 6), both hDcp2 and Hedls copurify with hDcp1a when all three are coexpressed ( Figure 2B , lanes 2 and 5). By contrast, neither hEdc3 nor Rck/p54 promote the association between hDcp1a and hDcp2 (data not shown). It is not clear whether Hedls performs a direct bridging function or plays a more indirect role in hDcp1a-hDcp2 complex formation. Interestingly, hDcp2, which readily copurifies with Hedls ( Figure 2A , lane 4), consistently accumulates at about 10-to 20-fold higher levels in the presence of coexpressed Hedls ( Figure 2B , compare lane 6 with lanes 1-5; accordingly, plasmid levels in Figure 2A were adjusted to achieve similar hDcp2 expression levels for each lane). It is therefore conceivable that Hedls affects hDcp2 in a manner that stabilizes hDcp2 and allows hDcp2 to associate with hDcp1a.
Rck/p54, hEdc3, and Hedls Colocalize with hDcp Proteins in PBs and Affect PB Morphology When Overexpressed We next wished to examine the intracellular localization of hDcp-associated proteins. HeLa cells were transfected with plasmids expressing Myc-tagged Hedls, Rck/p54, hEdc3, and hDcp1b. The cellular localization was compared to that of endogenous hDcp1a, which was used as a marker for PBs. To prevent an overexpression effect similar to that observed at high levels of FLAG-hDcp proteins ( Figure S1 ), we titrated the amount of plasmid DNA used for transfection. Myctagged Hedls, Rck/p54, hEdc3, and hDcp1b all colocalize with endogenous hDcp1a in PBs when expressed at low levels ( Figure 3A , 1-12). Myc-tagged hUpf1 served as a negative control and did not concentrate in PBs (Figure 3A, (13) (14) (15) . In addition, we also tested the localization of endogenous Hedls and hEdc3 by using our polyclonal antibodies and found that they colocalize in PBs with exogenous Myc-hDcp1a ( Figure 3B ).
To analyze the relationship between hDcp-associated proteins and PBs in more detail, we tested the effect of protein overexpression. In the absence of exogenous proteins, w70%-80% of HeLa cells contain PBs, as detected by using antibodies against endogenous hDcp1a and hXrn1 ( Figure 3C and data not shown). However, expression of high levels of hDcp2, Rck/p54, or hEdc3 leads to significant reduction or complete disappearance of endogenous hDcp1a and hXrn1 foci in 100% of transfected HeLa cells (compare transfected cells marked by arrowheads with untransfected cells in Figure 3C , 1-12). This result could reflect either the release of hDcp1a and hXrn1 from an unknown PB core or disassembly of the entire PB. Interestingly, however, overexpression of Hedls leads to the formation of multiple enlarged PB-like structures, which contain Hedls, hDcp1, and hXrn1 ( Figure 3C , 13-16). By contrast, overexpression of hUpf1 does not alter the localization of hDcp1a and hXrn1 in PBs (Figure 3C, (17) (18) (19) (20) . Taken together, the results in Figure 3 demonstrate that the decapping complex-associated proteins localize in PBs and affect PB morphology when overexpressed.
Overexpression of Hedls Leads to the Accumulation of Deadenylated ARE-Containing mRNA
The aberrant PB structures induced by exogenous Hedls appear similar to inactive PBs that form in S. cerevisiae (A) Western blots of anti-FLAG immunoprecipitates from RNasetreated extracts of HEK 293T cells transiently expressing FLAGtagged hDcp1a (lanes 1-3) or Hedls (lanes 4-6). Precipitates (top panels) and 5% of total extracts (input, bottom panels) were probed for the presence of coexpressed Myc-tagged hDcp2, Hedls, hDcp1a, or hnRNP A1, as indicated. (B) Western blots of proteins transiently coexpressed in HEK 293T cells from plasmids encoding Myc-Hedls (0 or 0.1 mg, as indicated), Myc-hDcp2 (0 to 1.6 mg, as indicated), FLAG-hDcp1a (0.5 mg), and Myc-hnRNP A1 (0.1 mg). pcDNA3 was added to achieve a total of 2.2 mg of plasmid in each reaction.
when PB components such as Xrn1, Dcp1, and Lsm1 are depleted (Sheth and Parker, 2003) . Such cells accumulate deadenylated mRNAs that, due to the absence of 5 0 to 3 0 decay, are only slowly degraded from the 3 0 end by the exosome (Anderson and Parker, 1998; Rodgers et al., 2002; Muhlrad et al., 1995) . In addition, similar aberrant PBs are observed in human cells after depletion of hXrn1 (Cougot et al., 2004a) . To test if HeLa cells that express exogenous Hedls behave in a similar manner, we analyzed the effect of overexpressed Hedls on the decay of an mRNA undergoing ARE-mediated decay (b-ARE; [Lykke-Andersen and Wagner, 2005] ). As seen in Figure 4A , overexpression of Hedls (lanes 6-10) leads to the accumulation of a b-ARE mRNA species (b-ARE-A 0 ), which is not observed in the absence of exogenous protein (lanes 11-15) or in the presence of exogenous hEdc3 (lanes 1-5) or any of the other decapping complex proteins (data not shown and Lykke-Andersen and Wagner [2005] ).
Treatment of the RNA samples in Figure 4A with RNase H and oligo-dT 24 revealed that the b-ARE-A 0 species comigrates with deadenylated b-ARE mRNA ( Figure  S5 ). In addition, b-ARE-A 0 mRNA copurifies with the cap binding protein eIF4E, but not with poly-A binding protein (PABP) ( Figure 4B , compare lanes 2 and 3). These data suggest that b-ARE-A 0 is deadenylated but capped. However, b-ARE-A 0 mRNA may be partially dissociated from eIF4E, and perhaps partially decapped, because less b-ARE-A 0 copurifies with eIF4E as compared to polyadenylated b-ARE mRNA ( Figure 4B , lane 3; 21% b-ARE-A 0 in eIF4E precipitates versus 44% in the input). By contrast, Hedls is preferentially associated with b-ARE-A 0 mRNA over polyadenylated b-ARE mRNA ( Figure 4B , lane 4; 80% b-ARE-A 0 in precipitates versus 45% in the input). We conclude that overexpression of Hedls leads to formation of aberrant PB structures ( Figure  3C ) and accumulation of a deadenylated ARE-containing mRNA species in complex with Hedls (Figure 4) . (4), and Myc-hDcp1a (2 and 5). Images are merged in 3 and 6 (Hedls and hEdc3, green; Myc-hDcp1a, red). (C) Same as (A) except that Myc-tagged proteins were overexpressed. Cells were stained for Myc-tagged proteins and endogenous hDcp1a or hXrn1, as indicated.
Hedls Enhances hDcp2 Activity In Vitro
The effect of overexpressed Hedls on PB morphology and ARE-mediated mRNA decay suggests that Hedls functions in mRNA turnover in the human cell. To test if Hedls plays a role in decapping, we tested the effect of Hedls on hDcp2 activity in vitro. FLAG-tagged hDcp2 and Hedls were immunopurified after transient overexpression in HEK 293T cells, and protein concentrations were estimated by comparison to a bacterially produced GST-FLAG protein of known concentration. As seen in the decapping assay in Figure 4C , Hedls strongly enhances hDcp2 activity (lanes 2-6). Hedls itself copurifies with little decapping activity (lane 7), but we cannot exclude the possibility that proteins that copurify with Hedls promote the effect on decapping. We conclude that Hedls is an enhancer of decapping. Considering that overexpressed proteins often inhibit the pathways in which they function, the accumulation of deadenylated ARE-containing mRNA induced by overexpressed Hedls in Figure 4A is likely a result of inhibition of the decapping step, perhaps due to sequestration of decapping subunits such as hDcp1a and hDcp2.
mRNA Decay Activator Proteins Interact with Specific Decapping Complex Subunits Decapping is activated in both NMD and ARE-mediated decay pathways (Lykke-Andersen and Wagner, 2005; Lejeune et al., 2003; He and Jacobson, 2001; Gao et al., 2001; Cao and Parker, 2003; . To ask how mRNA decay activator proteins associate with the decapping complex, we tested the ability of decapping factors to coimmunoprecipitate (from RNase-treated cell extracts) with hUpf1, an activator of NMD, and TTP, an activator of ARE-mediated decay. As seen in Figure 5A , TTP displays strong association with both hDcp2 and hEdc3 (lanes 5 and 11). By contrast, hUpf1 interacts with hDcp2, but not with hEdc3 (lanes 6 and 12). Due to protein overexpression, these results may reflect direct interactions, although we were unable to test this in vitro due to unsuccessful attempts at bacterially expressing GST fusions of TTP and hUpf1. Neither TTP nor hUpf1 associate with Rck/p54 (lanes 7-9) or Hedls (lanes 13-15), whereas weak association was observed with hDcp1a (lanes 1-3). As expected, no interaction was observed with the negative control protein hnRNP A1 (lanes 16-18).
TTP Activates Decapping of an ARE-Containing RNA In Vitro
The observation that TTP copurifies with hDcp2 suggested that TTP might be able to directly recruit and activate hDcp2 on an ARE-containing mRNA. We tested this hypothesis by using in vitro decapping assays. The results in Figure 5B show that FLAG-tagged TTP purified from human cells strongly enhances the activity of hDcp2 on an RNA that contains the ARE from GM-CSF mRNA (ARE; top, compare lanes 3-7 with lane 2). Maximal activity (20-to 100-fold enhancement in four independent experiments) is observed at an w5-fold excess of TTP over hDcp2 (lane 5). By contrast, a similar RNA with a mutant ARE sequence only supports weak enhancement of decapping by TTP (ARE-mut; bottom, lanes 2-7). In the absence of TTP, we observed no difference in the ability of hDcp2 to decap the ARE and AREmut RNAs (lane 2, and data not shown). TTP alone does not copurify with detectable decapping activity (lane 8). In contrast to TTP, the RNA binding protein hnRNP A1 does not activate decapping of either RNA substrate but appears in some experiments to inhibit decapping (lanes 9-12 and data not shown).
We next tested whether activation of decapping by TTP requires the ability of TTP to associate with RNA and hDcp2. Importantly, a mutant TTP protein (TTP F126N) that fails to associate with RNA (Blackshear, 2002; Lykke-Andersen and Wagner, 2005) does not activate decapping ( Figure 5C , compare lanes 7-9 with lanes 3-5). Similarly, TTP deleted of the N-terminal domain (TTP DNTD), which fails to interact with hDcp2 (Lykke-Andersen and Wagner, 2005), shows little enhancement of decapping ( Figure 5C , compare lanes 11-13 with lanes 3-5). We conclude that TTP enhances decapping of an ARE-containing RNA in vitro and that this activity is critically dependent on the interaction of TTP with both RNA and hDcp2. However, we cannot exclude the possibility that unknown proteins that copurify with TTP or hDcp2 mediate the activation.
A Decapping Complex Interacts with mRNA Decay Activator Proteins and Is Stimulated on ARE-RNA by TTP To better understand the complex formation between hDcp and hDcp-associated proteins identified in Figure 1, we performed a number of coimmunoprecipitation and in vitro pull-down assays ( Figures S4 and S6) . The following observations support the interactions illustrated in Figure 6A , in which hDcp2-Hedls and hEdc3-Rck/p54 complexes each interact with hDcp1a. First, the following overexpressed heterodimeric complexes are consistently observed in coimmunoprecipitation assays: hDcp2-Hedls, hDcp1a-hEdc3, and hEdc3-Rck/ p54 ( Figure S6 ). Second, Hedls and hDcp2 associate with hDcp1a only when coexpressed ( Figure 2A and Figure S4) . Third, Rck/p54 exists in complex with hDcp1a when hEdc3 is also present ( Figure S4 ). It is important to note that it is not clear whether the complex illustrated in Figure 6A exists in the cell and that additional interactions may take place.
To test if the mRNA decay activator proteins hUpf1 and TTP associate with more complex decapping assemblies than the hDcp2 protein itself, we tested the ability of coexpressed hDcp and hDcp-associated proteins to coimmunopurify with TTP and hUpf1. As seen in Figure 6B , when coexpressed, each decapping subunit copurifies with hUpf1 and TTP, with the possible exception of Rck/p54, which we were unable to detect due to its comigration with IgGs (lanes 2 and 3). This contrasts the observations with individually expressed subunits ( Figure 5A ) and demonstrates that some subunits only associate with hUpf1 and TTP when part of larger assemblies. As expected, decapping subunits did not associate with TTP-DNTD (lane 4) or with the anti-FLAG resin (lane 1). We conclude that TTP and hUpf1 exist in complex with multisubunit decapping complex assemblies.
To test the decapping activity and stimulation by TTP of a larger hDcp2-containing decapping complex assembly, we purified a FLAG-hEdc3 decapping complex. As seen in the coimmunoprecipitation assays in Figure 6C , where the importance of individual subunits for FLAG-hEdc3 decapping complex formation was tested, hDcp2 only copurifies with hEdc3 when both hDcp1a and Hedls are coexpressed (compare lanes 4 and 5 with 1-3). By contrast, Rck/p54 does not require other factors for hEdc3 association (lane 1). This suggests that the FLAG-hEdc3 complex purified in Figure 6C , lane 5, consists of an hDcp2-containing complex that contains at least four subunits, hEdc3, hDcp1a, Hedls, and hDcp2 (corresponding to lanes 4 and 5), as well as smaller complexes of hEdc3 with hDcp1a and/or Rck/ p54, in the absence of hDcp2 and Hedls (corresponding to lanes 1-3). However, these smaller FLAG-hEdc3 complexes would be expected to be catalytically inactive due to the absence of hDcp2. Consistent with this, when the FLAG-hEdc3 complex was subjected to gel filtration, hDcp2 and Hedls were found exclusively in a large (>2 MDa) fraction that also contains hDcp1a, whereas smaller complexes contain Rck/p54, hDcp1a, and hEdc3 only ( Figure S7A ). Some Rck/p54 is also observed in the >2 MDa FLAG-hEdc3 fraction, although at substochiometric amounts. Interestingly, a peak of endogenous hDcp1a, Hedls, and hEdc3 proteins is observed in the same >2 MDa fractions of extracts from untransfected cells, suggesting that it may correspond to an endogenous complex ( Figure S7B ).
We next tested the ability of TTP to enhance the activity of the FLAG-hEdc3 complex. As seen in Figure 6D , TTP enhances the decapping of an ARE-containing RNA by this decapping complex (w2-fold; compare lanes 2 and 1), although not to the same extent as observed with hDcp2 alone ( Figure 5B ). This suggests that the FLAG-hEdc3 complex does not, to the same extent as the hDcp2 subunit, depend on trans-acting factors for decapping in vitro. Perhaps one or more of the decapping complex subunits help recruit hDcp2 to the RNA substrate, which may limit the dependence on TTP. As expected, the small FLAG-hEdc3 complexes that do not contain hDcp2 are not contributing to decapping activity, because a FLAG-hEdc3 complex purified in the same manner, but containing an inactive hDcp2 mutant protein (E148Q; [Lykke-Andersen, 2002] ) in place of hDcp2, did not possess decapping activity (mut; lanes 4 and 5). Moreover, TTP alone was inactive (lanes 3 and 6). Interestingly, the input level of hDcp2 in the FLAG-hEdc3 complex used in Figure 6D was estimated by Western blotting to be at least 25-fold lower (w0.4 nM) than the uncomplexed hDcp2 in Figures 4C , 5B, and 5C (w10 nM), which suggests that hDcp2 is at least 25-fold more active when in the complex purified through FLAG-hEdc3. We conclude that a large decapping complex copurifies with activators of mRNA decay and is activated by TTP in vitro.
Discussion Hedls Promotes the Interaction between hDcp1a and hDcp2
In this study, we uncovered three proteins, Hedls, Rck/ p54, and hEdc3, that copurify with hDcp1. Homologs of Rck/p54 and hEdc3 were previously implicated in decapping in yeast. By contrast, Hedls has not previously been associated with decapping. The following observations suggest that Hedls is important in human decapping. First, Hedls associates with hDcp2 ( Figure 2A and Figure S6 ) and stimulates hDcp2 activity in vitro ( Figure 4C ). Second, overexpressed hDcp1a and hDcp2 do not form a complex unless Hedls is coexpressed (Figure 2A and Figure S4 ). Third, overexpression of Hedls causes accumulation of deadenylated exogenously expressed mRNA (b-ARE-A 0 ; Figure 4A ) and formation of aberrant PBs ( Figure 3C ) similar to those observed in yeast and human cells deficient in decapping or 5 0 to 3 0 exonucleolytic decay (Andrei et al., 2005; Cougot et al., 2004a; Sheth and Parker, 2003) . Interestingly, b-ARE-A 0 appears to be partially dissociated from eIF4E but specifically associates with Hedls ( Figure 4B ), suggesting that it may accumulate in the aberrant PBs induced by Hedls overexpression. These observations support an important role for Hedls in human decapping. It was surprising that overexpressed hDcp1a and hDcp2 depend on Hedls for complex formation (Figure 2A) . However, this is consistent with previous observations that bacterially produced hDcp1a does not stimulate hDcp2 activity in vitro (Lykke-Andersen, 2002; van Dijk et al., 2002) . By contrast, yeast Dcp1 and Dcp2 form a decapping complex in vitro (Steiger et al., 2003) . Interestingly, no Hedls ortholog is identifiable in the genome of S. cerevisiae, whereas putative Hedls orthologs can be identified in sequenced genomes of metazoans (data not shown). It is unclear why overexpressed hDcp1a and hDcp2, in contrast to their yeast orthologs, require Hedls for complex formation. Hedls may either form a bridge between hDcp1 and hDcp2, or alternatively, Hedls may mediate folding or modification of hDcp2, which in turn promotes direct interaction between hDcp2 and hDcp1. The observation that Hedls stabilizes overexpressed hDcp2 ( Figure 2B ) may support the latter hypothesis.
hDcp2 Is Observed in Multisubunit Complexes
The enzyme responsible for mRNA decapping in eukaryotic cells has been thought of as a heterodimeric complex between Dcp2 and Dcp1 (Lykke-Andersen, 2002; Piccirillo et al., 2003; van Dijk et al., 2002; Wang et al., 2002; Steiger et al., 2003) . However, the following observations suggest that hDcp2 may also exist in larger decapping complex assemblies in human cells. First, overexpressed hDcp1a and hDcp2 depend on Hedls for association ( Figure 2A and Figure S4 ). Second, hDcp2 copurifies with hEdc3 from HEK 293T cell extracts when coexpressed with Hedls and hDcp1a ( Figure 6C ). Third, some decapping subunits copurify with the mRNA decay activator proteins TTP and hUpf1 only when other subunits are coexpressed ( Figure 6B ). These results suggest that hDcp1a and hDcp2 exist in the cell in multisubunit complexes. Moreover, the observation that a fraction of each decapping complex subunit comigrates in a several-MDa fraction over a gel filtration column ( Figure S7 ) suggests that they can form multimeric complexes in the cell. It is not possible from our data to discriminate between the possibilities that the decapping enzyme hDcp2 functions in the cell solely in the context of multisubunit decapping complexes or if hDcp2 also functions on its own. Nevertheless, it is important to note that yeast cells depleted of Dcp1 are inactive in decapping, whereas depletion of Dhh1 (the homolog of Rck/p54) and Edc3 impairs decapping, and Edc3 depletion is deleterious when combined with mutations that weaken Dcp1 or Dcp2 function (Kshirsagar and Parker, 2004; Fischer and Weis, 2002; Coller et al., 2001; Beelman et al., 1996) . Moreover, we observed that hDcp2 activity is greatly enhanced by the association with other decapping subunits ( Figures 4C and 6D ). These observations support the importance of larger hDcp2-containing complexes in decapping.
The Relation between the Decapping Subunits and PBs
The following observations suggest that the hDcpassociated proteins are important components of PBs (Figure 7) . First, endogenous Hedls and hEdc3, and Hedls, Rck/p54, and hEdc3 transiently expressed at low levels, colocalize with hDcp1a in PBs ( Figures 3A  and 3B ). Second, overexpression of hDcp2, Rck/p54, or hEdc3 causes delocalization of endogenous hDcp1a and hXrn1, possibly due to sequestration of PB components ( Figure 3C ). Third, overexpression of Hedls leads to the formation of aberrant PBs and affects ARE-mediated mRNA decay ( Figures 3C and 4 ). An interesting question is how the decapping complex subunits and PBs are integrated in mRNA decay pathways. The observation that overexpression of hEdc3, Rck/p54, or hDcp2 leads to dissociation of visible PBs ( Figure 3C ), but has no negative effect on reporter mRNAs undergoing NMD or ARE-mediated decay ( Figure 4A and Lykke-Andersen and Wagner, 2005), suggests that formation of microscopically visible PBs is not a prerequisite for these mRNA decay pathways. It is possible that smaller PBs, undetectable by fluorescence microscopy, are formed under these conditions or that hXrn1 and the decapping complex can function outside of the PB. By contrast, the formation of aberrant PBs induced by overexpression of Hedls ( Figure 3C ) or by depletion of PB components correlates with impaired mRNA decay (Figure 4) (Cougot et al., 2004a; Sheth and Parker, 2003) . Perhaps PBs function as 5 0 to 3 0 exonucleolytic mRNA decay ''machines,'' much like the multisubunit exosome is thought to act in conjunction with a specialized decapping enzyme (DcpS) in 3 0 to 5 0 exonucleolytic decay (Liu et al., 2002; Raijmakers et al., 2004) . Future studies should show what fraction of mRNA decay in the human cell takes place in PBs.
The Role of Decapping in Regulated mRNA Decay Our results suggest that the decapping complex is important for NMD and ARE-mediated decay pathways. First, key factors in NMD and ARE-mediated decay associate with hDcp1a and hDcp2 ( Figure 5A ) (LykkeAndersen, 2002; Lykke-Andersen and Wagner, 2005) . Second, TTP activates ARE-mediated decapping in vitro ( Figures 5B, 5C , and 6D). We were unable to test hUpf1 in a similar manner, because its mechanism of RNA binding is not well defined. Third, both hUpf1 and TTP associate with (undefined) decapping complexes formed by coexpressed hDcp and hDcp-associated subunits ( Figure 6B ). Importantly, the N-terminal domain of TTP is necessary for both the interaction between TTP and the decapping complexes and for enhancement of decapping in vitro ( Figures 6B and 5C ). Interestingly, in contrast to hUpf1, TTP was found in complex with hEdc3 ( Figure 5A ). These results suggest that mRNA decay activators may communicate with the decapping complex through different proteins (Figure 7) . Such an organization may allow for specific pathway control while at the same time utilizing common decay components. In this scenario, it could be speculated that the cell by manipulating hEdc3 function might influence ARE-mediated decay while at the same time leaving the NMD pathway untouched. Alternatively, decapping complexes lacking hEdc3 may exist that function in NMD, but not in ARE-mediated mRNA decay. Interestingly, yeast Edc3 plays a role in both general decapping and in the regulated decapping of RPS28b mRNA (Badis et al., 2004; Kshirsagar and Parker, 2004) . Understanding the mechanism and regulation of activation of the decapping complex by specific mRNA decay pathways remains an important goal for future studies.
Experimental Procedures
Plasmid Constructs Plasmids expressing FLAG-and Myc-tagged proteins are described in the Supplemental Data.
Mass Spectrometry
Three 15 cm dishes of the stable cell lines expressing FLAG-hDcp proteins, at w80%-90% confluency, were induced overnight with tetracycline at 30 ng/ml. RNase-treated cell extracts were prepared as described earlier (Lykke-Andersen, 2002), 1 mg/ml of a FLAGpeptide (Sigma) was added, and the extracts were subjected to affinity purification by using anti-FLAG M2 agarose (Sigma). Precipitates were alkylated, gel purified, and trypsinized by standard procedures (see Supplemental Data). The proteins hDcp1a, hDcp1b, HSPA1L, hEdc3, and Rck/p54 were identified by using MALDI spectrometry, and Hedls was identified by LC-MS/MS spectrometry.
Antibodies
Rabbit polyclonal antisera were raised (Cocalico Biologicals Inc, Reamstown, PA) against hDcp1b (amino acids 1-264), hDcp2 (amino acids 1-179), Hedls (amino acids 1-152), and hEdc3 (amino acids 1-109) in fusion with GST. Mouse monoclonal anti-HuR 3A2 (Gallouzi et al., 2000) , and rabbit polyclonal anti-hDcp1a and anti-hXrn1 antibodies (Lykke-Andersen and Wagner, 2005) were described earlier.
Indirect Immunofluorescence
For colocalization experiments, w8 3 10 5 HeLa cells in DMEM/10% FBS in 3.5 cm wells were transfected by using TransIT HeLaMonster (Mirus) according to the manufacturers protocols, with 20-500 ng ( Figure 3A ) or 2 mg ( Figure 3C ) pcDNA3-Myc-Hedls, -Rck/p54, -hEdc3, -hDcp1b, -hDcp2, or -hUpf1 plasmids or 0.2 mg pcDNA3-Myc-hDcp1a ( Figure 3B ), and pcDNA3 was added to a total of 2 mg. Twenty-four hours after transfection, cells were trypsinized, and w2 3 10 4 cells were plated in 8-well chamber slides. Forty-eight hours after transfection, cells were fixed, permeabilized, and stained as described earlier (Lykke-Andersen et al., 2000 . Mouse antiMyc 9B11 monoclonal antibody (Cell Signaling) was used at 2 mg/ml and rabbit anti-hDcp1a, anti-Hedls, anti-hEdc3, and anti-hXrn1 antisera at 1:200, 1:200, 1:200, and 1:100, respectively.
Immunoprecipitation Assays
Coimmunoprecipitation assays between exogenously expressed FLAG-and Myc-tagged proteins were performed from transiently transfected HEK 293T cells with anti-FLAG M2 agarose (Sigma), as described earlier (Lykke-Andersen, 2002) . Western blotting was with mouse monoclonal anti-Myc 9B11 antibody (Cell Signaling). 
Decapping Assays
Decapping assays were performed as described earlier (LykkeAndersen, 2002) , except that 0.1 mM ZnCl 2 was added to the reactions containing TTP. Cap-labeled RNA substrates used in decapping assays were either a 105 nucleotide RNA containing the ARE from GM-CSF mRNA or a mutant version thereof with mutated AUUUA sequences, as described by Voeltz and Steitz (1998) . Proteins used in decapping assays were all immunopurified FLAG-tagged proteins transiently overexpressed in HEK 293T cells (Lykke-Andersen, 2002) .
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and seven figures and can be found with this article online at http:// www.molecule.org/cgi/content/full/20/6/905/DC1/.
